# Definium Therapeutics, Inc.: Form 8-K, filed Oct 31, 2025

- Company: [Definium Therapeutics, Inc.](/companies/dftx.md) (CIK 1813814)
- Form: 8-K
- Filed: 2025-10-31
- Accepted by EDGAR: Oct 31, 2025, 09:22 ET
- Period: 2025-10-29
- Accession: 0001104659-25-104696
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1813814/000110465925104696/tm2529910d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1813814/000110465925104696/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1813814/000110465925104696/tm2529910d1_8k.htm

Filed Oct 31, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-104696. Last ingested by Listed: Nov 5, 2026, 13:55 ET. No prices; not investment advice.